EUVIMEDEUVIMED entdecken
Open Access

IFN-λ3 is induced by Leishmania donovani and can inhibit parasite growth in cell line models but not in the mouse model, while it shows a significant association with leishmaniasis in humans

Manjarika De, Soumi Sukla, Seema Bharatiya, Sagar Keshri, Debarati Guha Roy, Sutopa Roy, Debrupa Dutta, Shriya Saha, Sarfaraz Ahmad Ejazi, V Ravichandiran, Nahid Ali iD, Mitali Chatterjee und 1 weitere

Infection and Immunity · 2024

DOI: 10.1128/iai.00504-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Immunity, 2024. Verfasst von Manjarika De und 12 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Biomedical Genomics, Kalyani, West Bengal, India. Hauptthemen laut MEDLINE: Leishmania donovani, Leishmaniasis, Visceral, Parasites. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, National Institute of Biomedical Genomics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intracellular protozoan parasite Leishmania donovani causes debilitating human diseases that involve visceral and dermal manifestations. Type 3 interferons (IFNs), also referred to as lambda IFNs (IFNL, IFN-L, or IFN-λ), are known to play protective roles against intracellular pathogens at the epithelial surfaces. Herein, we show that L. donovani induces IFN-λ3 in human as well as mouse cell line-derived macrophages. Interestingly, IFN-λ3 treatment significantly decreased parasite load in infected cells , mainly by increasing reactive oxygen species production. Microscopic examination showed that IFN-λ3 inhibited uptake but not replication, while the phagocytic ability of the cells was not affected. This was confirmed by experiments that showed that IFN-λ3 could decrease parasite load only when added to the medium at earlier time points, either during or soon after parasite uptake, but had no effect on parasite load when added at 24 h post-infection, suggesting that an early event during parasite uptake was targeted. Furthermore, the parasites could overcome the inhibitory effect of IFN-λ3, which was added at earlier time points, within 2-3 days post-infection. BALB/c mice treated with IFN-λ3 before infection led to a significant increase in expression of IL-4 and ARG1 post-infection in the spleen and liver, respectively, and to different pathological changes, especially in the liver, but not to changes in parasite load. Treatment with IFN-λ3 during infection did not decrease the parasite load in the spleen either. However, IFN-λ3 was significantly increased in the sera of visceral leishmaniasis patients, and the IFNL genetic variant rs12979860 was significantly associated with susceptibility to leishmaniasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmania donovaniLeishmaniasis, VisceralParasitesAnimalsHumansMiceCell LineMacrophagesMice, Inbred BALB CInterleukinsInterferon Lambda

Stichwörter der Autor:innen

IFN-L3LeishmaniaLeishmania donovanipost-kala-azar dermal leishmaniasistype III IFNvisceral leishmaniasis

Substanzen

interferon-lambda, humanInterleukinsInterferon Lambdainterferon-lambda protein, mouse

Autor:innen und Institutionen

  • National Institute of Biomedical Genomics, Kalyani, West Bengal, India.
  • National Institute of Pharmaceutical Education and Research, Kolkata, West Bengal, India.
  • Centre for High Impact Neuroscience and Translational Applications (CHINTA), TCG-Centres for Research and Education in Science and Technology, Kolkata, West Bengal, India.
  • Regional Centre for Biotechnology, Faridabad, India.
  • Department of Pharmacology, Institute of Post-Graduate Medical Education and Research, Kolkata, India.
  • Infectious Diseases and Immunology Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.

ORCID-Profile: Nahid Ali, Sreedhar Chinnaswamy

Förderung

  • Wellcome Trust
  • National Institute of Biomedical Genomics

Zitieren

APA

De, M., Sukla, S., Bharatiya, S., Keshri, S., Roy, D. G., Roy, S., Dutta, D., Saha, S., Ejazi, S. A., Ravichandiran, V., Ali, N., Chatterjee, M., & Chinnaswamy, S. (2024). IFN-λ3 is induced by Leishmania donovani and can inhibit parasite growth in cell line models but not in the mouse model, while it shows a significant association with leishmaniasis in humans. Infection and Immunity. https://doi.org/10.1128/iai.00504-23

Vancouver

De M, Sukla S, Bharatiya S, Keshri S, Roy DG, Roy S, et al. IFN-λ3 is induced by Leishmania donovani and can inhibit parasite growth in cell line models but not in the mouse model, while it shows a significant association with leishmaniasis in humans. Infection and Immunity. 2024. doi:10.1128/iai.00504-23

BibTeX
@article{De2024,
  author = {De, Manjarika and Sukla, Soumi and Bharatiya, Seema and Keshri, Sagar and Roy, Debarati Guha and Roy, Sutopa and Dutta, Debrupa and Saha, Shriya and Ejazi, Sarfaraz Ahmad and Ravichandiran, V and Ali, Nahid and Chatterjee, Mitali and Chinnaswamy, Sreedhar},
  title = {IFN-λ3 is induced by Leishmania donovani and can inhibit parasite growth in cell line models but not in the mouse model, while it shows a significant association with leishmaniasis in humans},
  journal = {Infection and Immunity},
  year = {2024},
  doi = {10.1128/iai.00504-23}
}
Kostenlos starten →